Abstract
We previously showed that a vector:lipid delivery system, comprised of a plasmid DNA vector and cationic lipid (lipoplex), when injected into the cerebrospinal fluid (CSF) of rats can deliver reporter genes in vivo efficiently and with widespread expression to the Central Nervous System (CNS). To further characterize this delivery system, we now present experiments that demonstrate the in vivo time-to-peak expression of the reporter gene, firefly luciferase. We infused a formulated lipoplex containing the lipid MLRI [dissymmetric myristoyl (14:0) and lauroyl (12:1) rosenthal inhibitor-substituted compound formed from the tetraalkylammonium glycerol-based DORI] and pNDluc, a luciferase vector, into CSF in the cisterna magna (CM) of the rat. Luciferase activity was followed over time by bioluminescence imaging after injection of luciferin. Our results show that luciferase activity in the CNS of rats is widespread, peaks 72 hours after injection into CM and can be detected in vivo for at least 7-10 days after peak expression. We further show that in contrast to injection into CSF, enzyme activity is not widely distributed after injection of the vector into brain parenchyma, emphasizing the importance of CSF delivery to achieve wid...Continue Reading
References
Jul 25, 1991·Nucleic Acids Research·B S ChapmanN L Haigwood
Mar 29, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·J G HeckerV R Irion
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·S Bhaumik, S S Gambhir
Sep 28, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Edmund J NiedzinskiMichael H Nantz
Feb 8, 2003·Human Gene Therapy·Yun ZhangWilliam M Pardridge
Mar 18, 2003·Human Gene Therapy·Dua M AndersonJames G Hecker
Aug 19, 2003·Molecular Imaging·Alnawaz RehemtullaBrian D Ross
Sep 10, 2003·Nuclear Medicine Communications·K-H LeeB-T Kim
Oct 18, 2003·Science·S Hacein-Bey-AbinaM Cavazzana-Calvo
Aug 7, 2004·Molecular Imaging·Zain ParooRalph P Mason
Feb 25, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Bakhos A TannousXandra O Breakefield
Feb 7, 2006·Current Gene Therapy·John R OhlfestDavid A Largaespada
Apr 21, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Arthur W NienhuisBrian P Sorrentino
Apr 28, 2006·Nature·Niels-Bjarne WoodsInder M Verma
May 3, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Piotr HadaczekKrystof Bankiewicz
Jun 2, 2006·Analytical Biochemistry·Garrett R RettigKevin G Rice
Sep 1, 2006·Gene Therapy·J R PinedaJ M Canals
Sep 6, 2006·Gene Therapy·S-D Li, L Huang
Apr 6, 2007·The AAPS Journal·Xiang GaoDexi Liu
Jun 20, 2007·Journal of Cellular Physiology·Terence R Flotte
Jul 21, 2007·Journal of Neurosurgery·Seunguk OhJohn R Ohlfest
Sep 21, 2007·Gene Therapy·V JosserandJ-L Coll
Nov 13, 2007·Journal of Biomedical Optics·Tewfik MiloudGünter J Hämmerling
Citations
Jul 8, 2011·Molecular Pharmaceutics·Srikanth YellayiJames G Hecker
Aug 29, 2009·Cancer Gene Therapy·J CutreraS Li
Nov 17, 2009·Tissue Engineering. Part a·Eliana C MartinezTheo Kofidis
Sep 26, 2008·International Archives of Medicine·Ti-Fei Yuan, Oscar Arias-Carrión
Feb 24, 2009·Advanced Drug Delivery Reviews·Jian WuNipavan Chiamvimonvat
Apr 28, 2011·Molecular Imaging·David M YurekAssem G Ziady
Nov 17, 2016·Frontiers in Molecular Neuroscience·James-Kevin Y TanPhilip J Horner
Mar 7, 2020·Advanced Drug Delivery Reviews·M J FowlerR W Sirianni
Mar 18, 2010·Molecular Pharmaceutics·Michael H NantzJames G Hecker
Jan 19, 2010·International Journal of Pharmaceutics·S ZouJ G Hecker
Mar 6, 2010·Tetrahedron Letters·Souvik BiswasMichael H Nantz